Fritextsökning
Innehållstyper
-
Fortsatt högtryck i svensk export
Fortsatt positiv syn på exporten bland svenska företag visar Business Swedens färska siffror.
-
Lundbeck divests companies
The company sells all shares in one listed company plus divests four small private equity funds, for a three-figured million sum.
-
Glucose facilitates the use of indigo
The Finnish researcher Anne Vuorema oat the MTT Agrifood Research Finland proves in her new doctoral dissertation that glucose can serve as a reducing agent of indigo.
-
Trio goes in for high tech medicines
The Swedish drug discovery company Beactica announces fragment-based drug discovery research collaboration with GE Healthcare and the University of Uppsala.
-
Danish discovery could help cardiac patients
The Danish researchers have developed a component that could make live easier forpatients with heart failure.
-
Biotage is regrouping
The Swedish company Biotage takes yet another step in streamlining efforts, by outsourcing all instrument production to contract manufacturers.
-
Medicult disclaims Swedish offer
The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.
-
Episurf tar in pengar
Planerar två emissioner och anställer ny finanschef.
-
Biogaia's advance goes on
In December Biogaia reached China and North America. Now, the Swedish probiotic company has entered the Mexican market.
-
Vattenfall is firing with biomass
Vattenfall will provide Denmark with electricity by means of biomass.
-
Rapid and thorough homogenization of samples
MP Biomedicals presents the Fasprep-24 instrument, a new high-throughput model of the earlier Bio 101 Systems Fastprep homogenizer.
-
Ten recieve the Venture Cup West Prize
At this year´s Venture Cup West awards the 10 best business ideas in Venture Cup West 08/09 were chosen, receiving SEK 10 000 each.
-
Collaboration brings next generation drugs
Wyeth and Santaris Pharma announce a new alliance to develop RNA-based medicines.
-
Cykel till Silviahemmet
Brighter inleder samarbete med Silviahemmet genom att erbjuda sin innovation jDome BikeAround till demenshemmets patienter.
-
Biosimilarer ger prispress, men används de tillräckligt?
Biosimilarernas ankomst för drygt 16 år sedan väckte hopp om att många fler patienter skulle få tillgång till effektiva men annars mycket dyra behandlingar med ...
-
Symphogen buys tumor blocking technology
The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten ...
-
Age essential when testing drugs
Anders Rane has been arguing that genes and age are both important factors in understanding how medicines affect individuals. Only last year, the EU established...
-
Rosling-kurs på KI för alla
Nu finns en online-kurs i global hälsa baserad på Hans Roslings kunskaper och metoder. Kursen vid KI är öppen för alla.
-
Slutar söka patent i låginkomstländer
- I lågutvecklade och låginkomstländer kommer vi från och med nu inte att söka patent alls. I fattigare medelinkomstländer kommer vi att söka patent men även ge...
-
Snart faller klubban för Astrazeneca
I dag torsdag hålls slutpläderingarna i det första pay-for-delay-fallet i USA, som kan ge läkemedelsbolaget miljarder dollar i böter.
-
Re-painting the big pig-ture
Why do tame pigs show such variety in colouring, when their wild relatives are so plain? Swedish researchers know who is to blame. But the big question is why.
-
Printing sensors for biological samples
Acreo develops technologies for printed electronics. Using organic printers, Acreo can print a transistor where biological samples can be placed.
-
Neurovive inleder fas II-studie
Första patienten rekryterad till studien Ciprics, på akut njurskada vid hjärtkirurgi.
-
Platelet analysis in whole blood
The new Multiplate analyzer from Triolab uses impedance aggregometry to measure the effects of platelet inhibitors on whole blood.